$-0.22 EPS Expected for Cellect Biotechnology Ltd (APOP); Atlantica Yield Plc Ord (ABY) SI Increased By 10.67%

June 12, 2017 - By Richard Conner

Atlantica Yield Plc Ord (NASDAQ:ABY) had an increase of 10.67% in short interest. ABY’s SI was 1.20M shares in June as released by FINRA. Its up 10.67% from 1.08M shares previously. With 431,900 avg volume, 3 days are for Atlantica Yield Plc Ord (NASDAQ:ABY)’s short sellers to cover ABY’s short positions. The SI to Atlantica Yield Plc Ord’s float is 1.24%. The stock decreased 0.05% or $0.01 on June 9, reaching $21. About shares traded. Atlantica Yield PLC (NASDAQ:ABY) has risen 10.39% since June 12, 2016 and is uptrending. It has underperformed by 6.31% the S&P500.

Analysts expect Cellect Biotechnology Ltd (TLV:APOP) to report $-0.22 EPS on July, 7.After having $-0.01 EPS previously, Cellect Biotechnology Ltd’s analysts see 2,100.00% EPS growth. About 624,683 shares traded or 44.91% up from the average. Cellect Biotechnology Ltd (TLV:APOP) has 0.00% since June 12, 2016 and is . It has underperformed by 16.70% the S&P500.

Cellect Biotechnology Ltd, formerly Cellect Biomed Ltd, is an Israel firm engaged in regenerative medicine through the development of products facilitating immune stem cell selection. The company has market cap of $157.26 million. The Company’s platform technology is based on the game changing perception that the functional properties of stem cells rather than appearance should be used for their identification, selection and utilization. It currently has negative earnings. The Company’s first product is designed to harness the critical function of sensitivity to specific apoptosis-inducing agents.

Atlantica Yield plc, formerly Abengoa Yield plc, is a total return company. The company has market cap of $2.10 billion. The Firm owns, manages, and acquires renewable energy, conventional power, electric transmission lines and water assets, focused on North America , South America (Peru, Chile, Brazil and Uruguay) and Europe, Middle East and Africa (Spain, Algeria and South Africa). It has a 224.33 P/E ratio. The Company’s divisions include North America, South America and EMEA.

Among 4 analysts covering Abengoa Yield (NASDAQ:ABY), 0 have Buy rating, 1 Sell and 3 Hold. Therefore 0 are positive. Abengoa Yield has $47 highest and $16 lowest target. $21.80’s average target is 3.81% above currents $21 stock price. Abengoa Yield had 9 analyst reports since August 3, 2015 according to SRatingsIntel. RBC Capital Markets maintained the stock with “Outperform” rating in Monday, August 3 report. Canaccord Genuity downgraded it to “Hold” rating and $16.0 target in Monday, November 30 report. The rating was downgraded by Bank of America on Tuesday, September 8 to “Neutral”. The stock has “Underperform” rating by Bank of America on Monday, November 30. The firm earned “Buy” rating on Tuesday, August 11 by Canaccord Genuity. The rating was downgraded by Morgan Stanley to “Equal-Weight” on Wednesday, September 30.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: